This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (578) Depression and Mood Disorders; Suicide Prevention (1383)

Published on in Vol 7, No 6 (2018): June

Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study

Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study

Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study

Authors of this article:

Tomiki Sumiyoshi1, 2 Author Orcid Image ;   Koichiro Watanabe3 Author Orcid Image ;   Shinichi Noto4 Author Orcid Image ;   Shigeru Sakamoto5 Author Orcid Image ;   Yoshiya Moriguchi6 Author Orcid Image ;   Shuichi Okamoto5 Author Orcid Image
Article Authors Cited by (9) Tweetations (3) Metrics

Journals

  1. Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Tan K, Hammer-Helmich L, Fernandez J. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J. Journal of Affective Disorders 2019;258:172 View
  2. Li X, Sun N, Yang C, Liu Z, Li X, Zhang K. C-Reactive Protein Gene Variants in Depressive Symptoms & Antidepressants Efficacy. Psychiatry Investigation 2019;16(12):940 View
  3. Sumiyoshi T, Watanabe K, Noto S, Sakamoto S, Moriguchi Y, Hammer-Helmich L, Fernandez J. Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J. Neuropsychiatric Disease and Treatment 2021;Volume 17:945 View
  4. Noto S, Wake M, Mishiro I, Hammer-Helmich L, Ren H, Moriguchi Y, Fujikawa K, Fernandez J. Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 2022;30:127 View
  5. Watanabe K, Marumoto T, Ge H, Moriguchi Y, Fujikawa K, Fernandez J. Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder. Journal of Psychiatric Research 2022;154:324 View
  6. Sumiyoshi T, Hoshino T, Mishiro I, Hammer-Helmich L, Ge H, Moriguchi Y, Fujikawa K, Fernandez J. Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder. Journal of Affective Disorders 2022;296:95 View
  7. Sumiyoshi T, Uchida H, Watanabe K, Oosawa M, Ren H, Moriguchi Y, Fujikawa K, Fernandez J. Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 2022;Volume 18:2507 View
  8. Toyoshima K, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I. The mediating role of depressive symptoms and subjective cognitive dysfunction in the relationship between stressful life events and functional disability in adult community volunteers. Journal of Affective Disorders 2023;330:110 View
  9. Kim H, Voineskos A, Neufeld N, Alexopoulos G, Bingham K, Flint A, Marino P, Rothschild A, Whyte E, Mulsant B. Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features. Molecular Psychiatry 2024;29(8):2459 View